Probiotic DR Capsule By Bronson Laboratories Overview & Drug Interactions
Check For Interactions With Probiotic DR Capsule
Supplement: Probiotic DR Capsule by Bronson Laboratories
Probiotic DR Capsule Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Bronson Probiotic Blend
| Ingredient Group | Proprietary Blend (non-nutrient/non-botanical) |
|---|---|
| Category | blend |
-
Bifidobacterium animalis ssp. lactis
Ingredient Group Bifidobacterium animalis lactis Category bacteria
Bifidobacterium longum
Ingredient Group Bifidobacterium longum Category bacteria
Lactobacillus acidophilus
Description:Lactobacillus acidophilus is a type of lactic acid-producing bacteria that is commonly found in the human gut, as well as in other areas of the body such as the mouth and vagina. L. acidophilus can also be found in fermented foods such as yogurt and kefir. It is commonly utilized in probiotic dietary supplements as it is considered a "friendly" or "beneficial" bacteria because it helps to maintain the balance of microorganisms in the body, and is purported to help improve digestion and boost the immune system. Some studies have suggested that L. acidophilus may also have a role in preventing and treating certain conditions such as diarrhea, vaginal yeast infections, and eczema.
See More Information Regarding Lactobacillus Acidophilus
Ingredient Group Lactobacillus acidophilus Category bacteria
Lactobacillus rhamnosus
Ingredient Group Lactobacillus rhamnosus Category bacteria
Bacillus coagulans
Description:Bacillus coagulans, also known as Weizmannia coagulans or Lactobacillus sporogenes, is a spore-forming, lactic acid-producing, Gram-positive bacterium used as a probiotic. Bacillus coagulans has shown benefits for constipation and irritable bowel syndrome (IBS). Its spores are stable in stomach acid and reach the small intestine, where they germinate and multiply, with around 85% reaching their destination. The bacterium is excreted via feces, with spores detectable up to 7 days post-administration. Mechanistically, Bacillus coagulans exhibits antibacterial effects through the production of coagulin, lactic acid, and lactosporin, reducing pathogenic bacteria colonization. It also demonstrates antifungal properties and anti-inflammatory effects, potentially reducing the growth of pathogenic bacteria and decreasing the production of lipopolysaccharides. Bacillus coagulans may stimulate immune response, as evidenced by increased CD4+ T cells in adults with HIV-1 infection and modulation of inflammatory cytokines in schoolchildren. These properties categorize Bacillus coagulans as an immunomodulator, immunostimulant, and probiotic, with potential therapeutic applications in promoting digestive health and immune function.
See More Information Regarding Bacillus Coagulans
Ingredient Group Bacillus Coagulans Category bacteria
Psyllium
Ingredient Group Psyllium (unspecified) Category botanical
FOS Inulin
Ingredient Group Fructo-Oligosaccharides (FOS) Category fiber
Drugs that interact with Probiotic DR Capsule by Bronson Laboratories
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
2 Capsule(s)
|
| Maximum serving Sizes: |
2 Capsule(s)
|
| UPC/BARCODE | 716563552015 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Bronson Probiotic Blend |
1400000000 CFU
|
Proprietary Blend (non-nutrient/non-botanical) |
--
|
| Bifidobacterium animalis ssp. lactis |
500000000 CFU
|
Bifidobacterium animalis lactis |
--
|
| Bifidobacterium longum |
250000000 CFU
|
Bifidobacterium longum |
--
|
| Lactobacillus acidophilus |
250000000 CFU
|
Lactobacillus acidophilus |
--
|
| Lactobacillus rhamnosus |
250000000 CFU
|
Lactobacillus rhamnosus |
--
|
| Bacillus coagulans |
150000000 CFU
|
Bacillus Coagulans |
--
|
| Psyllium |
300 mg
|
Psyllium (unspecified) |
--
|
| FOS Inulin |
100 mg
|
Fructo-Oligosaccharides (FOS) |
--
|
| Other Ingredients: |
Modified Cellulose
Microcrystalline Cellulose
Magnesium Stearate
Silicon Dioxide
|
|---|
Label Statments:
| General Statements |
- Probiotic DR Capsule (DR Capsule is a Delayed Release modified cellulose (HPMC) capsule.)
- Improving digestion with dual action of probiotics and enzymes
- DIGESTIVE SUPPORT EST 1960
- Made in USA
|
|---|---|
| Suggested/Recommended/Usage/Directions |
- Directions: As a dietary supplement for adults, 1 packet (2 capsules) once daily preferably with food or as directed by a health professional.
|
| Precautions |
- Do not take on an empty stomach.
- WARNING: Do not use if you are pregnant or nursing.
- Keep out of reach of children.
|
| FDA Statement of Identity |
- Dietary Supplement
|
| General |
- 552a REF 0513
|
| Storage |
- Store at room temperature.
Protect from light.
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Brand IP Statement(s) |
- Discover the Bronson Difference(R)
|
Brand Information
| Manufacturer | |
|---|---|
| Name | Bronson Laboratories |
| City | Lindon |
| State | UT |
| ZipCode | 84042 |
| For Information Call | |
| Phone Number | 1-800-235-3200 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.